Skip to main content
. 2021 Feb 4;4(2):e2036512. doi: 10.1001/jamanetworkopen.2020.36512

Table 1. Characteristics of a Cohort of 15 637 Transgender Adults and a Cohort of 46 911 Cisgender Adults in the US, 2017.

Characteristic No. (%) Bivariate comparisonsa
Transgender (n = 15 637) Cisgender (n = 46 911) χ2 P value
Geographic regionb
Northeast 1963 (12.6) 5889 (12.6) NA NA
Midwest 3760 (24.0) 11 280 (24.0)
West 3432 (21.9) 10 296 (21.9)
South 6482 (41.5) 19 446 (41.5)
Age, y
18-25 4084 (26.1) 12 252 (26.1) NA NA
26-30 1858 (11.9) 5574 (11.9)
31-35 1369 (8.8) 4107 (8.8)
36-40 1316 (8.4) 3948 (8.4)
41-45 1167 (7.5) 3501 (7.5)
45-50 1302 (8.3) 3906 (8.3)
51-55 1257 (8.0) 3771 (8.0)
56-60 1154 (7.4) 3462 (7.4)
≥61 2130 (13.6) 6390 (13.6)
Gender spectrum
Transfeminine 2079 (13.3) NA NA NA
Transmasculine 4955 (31.7) NA
Unknown gender 8603 (55.0) NA
Male NA 23 664 (50.4)
Female NA 23 247 (49.6)
SUDDs
Polysubstance 310 (2.0) 245 (0.5) 284.3 <.001
Nicotine 2594 (16.6) 2551 (5.4) 1931.7 <.001
Alcohol and drug 887 (5.7) 820 (1.7) 680.4 <.001
Alcohol 401 (2.6) 438 (0.9) 235.7 <.001
Drug 678 (4.3) 549 (1.2) 611.1 <.001
Cannabis 321 (2.1) 186 (0.4) 400.2 <.001
Cocaine 81 (0.5) 59 (0.1) 80.8 <.001
Opioid 205 (1.3) 207 (0.4) 135.6 <.001
Another drugc 265 (1.7) 183 (0.4) 280.7 <.001

Abbreviations: NA, not applicable; SUDD, substance use disorder diagnoses.

a

Bivariate comparisons are not reported for age and geographic region because the cisgender cohort was matched 3 to 1 to the transgender cohort based on these characteristics.

b

Hawaii and Alaska are included in the West according to the US Census. US territories (eg, Puerto Rico and Guam) are not included in US Census regions; thus the approximately 100 individuals without an assigned census region were included in the South.

c

Another drug SUDD includes hallucinogens, sedatives, stimulants, and the diagnosis of other SUD not otherwise specified.